Psoriasis vulgaris triggered by interferon beta therapy for multiple sclerosis treated with fumaric acid - 16/03/14
Spyridon Gkalpakiotis, MD, PhD, Department of Dermatovenereology, Third Faculty of Medicine, Charles University in Prague and Faculty Hospital of Kralovske Vinohrady, Prague, Czech Republic; Monika Arenbergerova, MD, PhD, Department of Dermatovenereology, Third Faculty of Medicine, Charles University in Prague and Faculty Hospital of Kralovske Vinohrady, Prague, Czech Republic; Petr Arenberger, MD, PhD, Department of Dermatovenereology, Third Faculty of Medicine, Charles University in Prague and Faculty Hospital of Kralovske Vinohrady, Prague, Czech Republic; Petra Gkalpakioti, MD, Department of Dermatovenereology, Third Faculty of Medicine, Charles University in Prague and Faculty Hospital of Kralovske Vinohrady, Prague, Czech Republic
Le texte complet de cet article est disponible en PDF. Commercial support: None identified. |
Vol 70 - N° 5S1
P. AB181 - mai 2014 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?